The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma
Open Access
- 1 January 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Brain
- Vol. 124 (1), 5-19
- https://doi.org/10.1093/brain/124.1.5
Abstract
The subthalamic nucleus (STN) currently is considered to play a key role in the pathophysiological origin of the parkinsonian state and is therefore the main target for surgical treatment of Parkinson's disease. The authors review the incidence of hemichorea/ballism (HCB) as a complication of thalamotomy, pallidotomy or campotomy procedures before the introduction of levodopa therapy, including the few reported cases accompanied by a neuropathological study. The literature shows that only a small number of parkinsonian patients with HCB had a lesion of the STN. Preliminary data in Parkinson's disease patients submitted to a subthalamotomy with current functional stereotaxy also indicate that HCB is a very rare complication. To explain this observation, we suggest that the parkinsonian state is characterized by an increased threshold for the induction of dyskinesia following STN lesioning. This arises as a consequence of reduced activity in the 'direct' GABA projection to the globus pallidus medialis (GPm) which accompanies dopamine depletion. Lesioning of the STN reduces excitation of the GPm, and theoretically this should induce dyskinesias. However, an STN lesion also, simultaneously, further reduces the hypoactivity in the globus pallidus lateralis (GPl) that is a feature of Parkinson's disease, and hence may compensate for GPm hypoactivity, thus self-stabilizing basal ganglia output activity and reducing the risk of HCB. We conclude that lesioning of the STN in Parkinson's disease is a feasible approach in some circumstances.Keywords
This publication has 78 references indexed in Scilit:
- Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkeyBrain Research, 1998
- Subthalamic nucleotomy alleviates parkinsonism in the 1 -methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-exposed primateBritish Journal Of Neurosurgery, 1992
- Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primateMovement Disorders, 1991
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- Neurological Side-Effects in a Series of Operations on the Basal GangliaJournal of Neurosurgery, 1966
- Subthalamotomy in Treatment of Parkinsonian TremorJournal of Neurosurgery, 1963
- Anatomic verification of the lesion which abolishes parkinsonian tremor and rigidityNeurology, 1963
- A CLINICAL AND RADIOLOGICAL CORRELATION OF THE LESIONS PRODUCED BY CHEMOPALLIDECTOMY AND THALAMECTOMYJournal of Neurology, Neurosurgery & Psychiatry, 1959
- Analysis of choreoid hyperkinesia in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus ol luysJournal of Comparative Neurology, 1950
- Über das Syndrom des Corpus Luys an Hand eines anatomisch untersuchten Falles von HemiballismusZeitschrift für die gesamte Neurologie und Psychiatrie, 1930